In Oncology Clinical Pathways, the Variability Isn’t With the Drugs

September 25, 2021 04:45pm

Experts who took part in Patient-Centered Oncology Care® 2021 said when guidelines recommend high-cost targeted therapies or immunotherapies, the focus must turn to areas such as imaging, diagnostic tests, and other elements that contribute to the cost of care.

In Cancer Care, Turning Attention to Transitions, SDOH
Smoking, Periodontitis Linked With Increased Risk of Psoriasis
Study: Immunosuppressant Withdrawal Feasible, Safe for Many Patients With SLE and Lupus Nephritis
What's Next After OCM? Possibly a Gap and Something Mandatory, Experts Predict